Trials / NCT00433277
Autoimmunity in Retinitis Pigmentosa
Status unknown N/A Drug / neuroprotection
- Sponsor
- Semmelweis University
- Treatment
- twice-daily dosage with 0.5% cyclosporine-A eyedrops
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- Any to no upper limit
- Enrollment
- Not stated participants
- Started
- Not stated
- Main results expected
- Not stated
- Results posted
- Not yet
- Record last updated
- 2007-02-09
What the study is testing
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.
Where it runs
Hungary (1)
- Semmelweis University, Dept. of Ophthalmology, Budapest